Global Liquid Biopsy For Cancer Diagnostics Market Growth (Status and Outlook) 2026-2032
The global Liquid Biopsy For Cancer Diagnostics market size is predicted to grow from US$ 4728 million in 2025 to US$ 10860 million in 2032; it is expected to grow at a CAGR of 12.9% from 2026 to 2032.
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
LPI (LP Information)' newest research report, the “Liquid Biopsy For Cancer Diagnostics Industry Forecast” looks at past sales and reviews total world Liquid Biopsy For Cancer Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy For Cancer Diagnostics sales for 2026 through 2032. With Liquid Biopsy For Cancer Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy For Cancer Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Liquid Biopsy For Cancer Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liquid Biopsy For Cancer Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid Biopsy For Cancer Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy For Cancer Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy For Cancer Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy For Cancer Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
LPI (LP Information)' newest research report, the “Liquid Biopsy For Cancer Diagnostics Industry Forecast” looks at past sales and reviews total world Liquid Biopsy For Cancer Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy For Cancer Diagnostics sales for 2026 through 2032. With Liquid Biopsy For Cancer Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy For Cancer Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Liquid Biopsy For Cancer Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liquid Biopsy For Cancer Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid Biopsy For Cancer Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy For Cancer Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy For Cancer Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy For Cancer Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Test
- Urine Test
- Saliva Test
- Hospital
- Diagnostic Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- F. Hoffman La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Illumina Inc.
- The Menarini Group
- Bio-Rad Laboratories Inc.
- QIAGEN Inc.
- Exact Sciences Corporation
- Bio-Techne Corporation
- ArcherDX Inc.
- Neogenomics Laboratories Inc.
- Guardant Health Inc.
- Myriad Genetics Inc.
- Foundation Medicine Inc.
- Amoy Diagnostics Co. Ltd.
- Biocartis Group NV
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liquid Biopsy For Cancer Diagnostics Market Size (2021-2032)
2.1.2 Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Liquid Biopsy For Cancer Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Liquid Biopsy For Cancer Diagnostics Segment by Type
2.2.1 Blood Test
2.2.2 Urine Test
2.2.3 Saliva Test
2.2.4 Liquid Biopsy For Cancer Diagnostics Market Size by Type
2.2.4.1 Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Liquid Biopsy For Cancer Diagnostics Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Center
2.3.3 Others
2.3.4 Liquid Biopsy For Cancer Diagnostics Market Size by Application
2.3.4.1 Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
3 LIQUID BIOPSY FOR CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Player
3.1.1 Global Liquid Biopsy For Cancer Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Liquid Biopsy For Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LIQUID BIOPSY FOR CANCER DIAGNOSTICS BY REGION
4.1 Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026)
4.2 Global Liquid Biopsy For Cancer Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
4.4 APAC Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
4.5 Europe Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026)
5.2 Americas Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
5.3 Americas Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026)
6.2 APAC Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
6.3 APAC Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026)
7.2 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
7.3 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liquid Biopsy For Cancer Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LIQUID BIOPSY FOR CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Liquid Biopsy For Cancer Diagnostics Forecast
10.1.3 APAC Liquid Biopsy For Cancer Diagnostics Forecast
10.1.4 Europe Liquid Biopsy For Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Forecast
10.2 Americas Liquid Biopsy For Cancer Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Liquid Biopsy For Cancer Diagnostics Forecast
10.2.2 Canada Market Liquid Biopsy For Cancer Diagnostics Forecast
10.2.3 Mexico Market Liquid Biopsy For Cancer Diagnostics Forecast
10.2.4 Brazil Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3 APAC Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.3.1 China Liquid Biopsy For Cancer Diagnostics Market Forecast
10.3.2 Japan Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.3 Korea Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.4 Southeast Asia Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.5 India Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.6 Australia Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4 Europe Liquid Biopsy For Cancer Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.2 France Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.3 UK Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.4 Italy Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.5 Russia Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5.2 South Africa Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5.3 Israel Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5.4 Turkey Market Liquid Biopsy For Cancer Diagnostics Forecast
10.6 Global Liquid Biopsy For Cancer Diagnostics Forecast by Type (2027-2032)
10.7 Global Liquid Biopsy For Cancer Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Liquid Biopsy For Cancer Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 F. Hoffman La Roche Ltd.
11.1.1 F. Hoffman La Roche Ltd. Company Information
11.1.2 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
11.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 F. Hoffman La Roche Ltd. Main Business Overview
11.1.5 F. Hoffman La Roche Ltd. Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Agilent Technologies Inc.
11.3.1 Agilent Technologies Inc. Company Information
11.3.2 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Agilent Technologies Inc. Main Business Overview
11.3.5 Agilent Technologies Inc. Latest Developments
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Information
11.4.2 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Illumina Inc. Main Business Overview
11.4.5 Illumina Inc. Latest Developments
11.5 The Menarini Group
11.5.1 The Menarini Group Company Information
11.5.2 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Offered
11.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 The Menarini Group Main Business Overview
11.5.5 The Menarini Group Latest Developments
11.6 Bio-Rad Laboratories Inc.
11.6.1 Bio-Rad Laboratories Inc. Company Information
11.6.2 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Rad Laboratories Inc. Main Business Overview
11.6.5 Bio-Rad Laboratories Inc. Latest Developments
11.7 QIAGEN Inc.
11.7.1 QIAGEN Inc. Company Information
11.7.2 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 QIAGEN Inc. Main Business Overview
11.7.5 QIAGEN Inc. Latest Developments
11.8 Exact Sciences Corporation
11.8.1 Exact Sciences Corporation Company Information
11.8.2 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
11.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Exact Sciences Corporation Main Business Overview
11.8.5 Exact Sciences Corporation Latest Developments
11.9 Bio-Techne Corporation
11.9.1 Bio-Techne Corporation Company Information
11.9.2 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
11.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bio-Techne Corporation Main Business Overview
11.9.5 Bio-Techne Corporation Latest Developments
11.10 ArcherDX Inc.
11.10.1 ArcherDX Inc. Company Information
11.10.2 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 ArcherDX Inc. Main Business Overview
11.10.5 ArcherDX Inc. Latest Developments
11.11 Neogenomics Laboratories Inc.
11.11.1 Neogenomics Laboratories Inc. Company Information
11.11.2 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Neogenomics Laboratories Inc. Main Business Overview
11.11.5 Neogenomics Laboratories Inc. Latest Developments
11.12 Guardant Health Inc.
11.12.1 Guardant Health Inc. Company Information
11.12.2 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Guardant Health Inc. Main Business Overview
11.12.5 Guardant Health Inc. Latest Developments
11.13 Myriad Genetics Inc.
11.13.1 Myriad Genetics Inc. Company Information
11.13.2 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Myriad Genetics Inc. Main Business Overview
11.13.5 Myriad Genetics Inc. Latest Developments
11.14 Foundation Medicine Inc.
11.14.1 Foundation Medicine Inc. Company Information
11.14.2 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Foundation Medicine Inc. Main Business Overview
11.14.5 Foundation Medicine Inc. Latest Developments
11.15 Amoy Diagnostics Co. Ltd.
11.15.1 Amoy Diagnostics Co. Ltd. Company Information
11.15.2 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
11.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Amoy Diagnostics Co. Ltd. Main Business Overview
11.15.5 Amoy Diagnostics Co. Ltd. Latest Developments
11.16 Biocartis Group NV
11.16.1 Biocartis Group NV Company Information
11.16.2 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Offered
11.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Biocartis Group NV Main Business Overview
11.16.5 Biocartis Group NV Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liquid Biopsy For Cancer Diagnostics Market Size (2021-2032)
2.1.2 Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Liquid Biopsy For Cancer Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Liquid Biopsy For Cancer Diagnostics Segment by Type
2.2.1 Blood Test
2.2.2 Urine Test
2.2.3 Saliva Test
2.2.4 Liquid Biopsy For Cancer Diagnostics Market Size by Type
2.2.4.1 Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Liquid Biopsy For Cancer Diagnostics Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Center
2.3.3 Others
2.3.4 Liquid Biopsy For Cancer Diagnostics Market Size by Application
2.3.4.1 Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
3 LIQUID BIOPSY FOR CANCER DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Player
3.1.1 Global Liquid Biopsy For Cancer Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Liquid Biopsy For Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LIQUID BIOPSY FOR CANCER DIAGNOSTICS BY REGION
4.1 Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026)
4.2 Global Liquid Biopsy For Cancer Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
4.4 APAC Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
4.5 Europe Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026)
5.2 Americas Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
5.3 Americas Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026)
6.2 APAC Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
6.3 APAC Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026)
7.2 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
7.3 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liquid Biopsy For Cancer Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LIQUID BIOPSY FOR CANCER DIAGNOSTICS MARKET FORECAST
10.1 Global Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Liquid Biopsy For Cancer Diagnostics Forecast
10.1.3 APAC Liquid Biopsy For Cancer Diagnostics Forecast
10.1.4 Europe Liquid Biopsy For Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Forecast
10.2 Americas Liquid Biopsy For Cancer Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Liquid Biopsy For Cancer Diagnostics Forecast
10.2.2 Canada Market Liquid Biopsy For Cancer Diagnostics Forecast
10.2.3 Mexico Market Liquid Biopsy For Cancer Diagnostics Forecast
10.2.4 Brazil Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3 APAC Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.3.1 China Liquid Biopsy For Cancer Diagnostics Market Forecast
10.3.2 Japan Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.3 Korea Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.4 Southeast Asia Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.5 India Market Liquid Biopsy For Cancer Diagnostics Forecast
10.3.6 Australia Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4 Europe Liquid Biopsy For Cancer Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.2 France Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.3 UK Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.4 Italy Market Liquid Biopsy For Cancer Diagnostics Forecast
10.4.5 Russia Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5.2 South Africa Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5.3 Israel Market Liquid Biopsy For Cancer Diagnostics Forecast
10.5.4 Turkey Market Liquid Biopsy For Cancer Diagnostics Forecast
10.6 Global Liquid Biopsy For Cancer Diagnostics Forecast by Type (2027-2032)
10.7 Global Liquid Biopsy For Cancer Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Liquid Biopsy For Cancer Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 F. Hoffman La Roche Ltd.
11.1.1 F. Hoffman La Roche Ltd. Company Information
11.1.2 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
11.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 F. Hoffman La Roche Ltd. Main Business Overview
11.1.5 F. Hoffman La Roche Ltd. Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Agilent Technologies Inc.
11.3.1 Agilent Technologies Inc. Company Information
11.3.2 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Agilent Technologies Inc. Main Business Overview
11.3.5 Agilent Technologies Inc. Latest Developments
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Information
11.4.2 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Illumina Inc. Main Business Overview
11.4.5 Illumina Inc. Latest Developments
11.5 The Menarini Group
11.5.1 The Menarini Group Company Information
11.5.2 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Offered
11.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 The Menarini Group Main Business Overview
11.5.5 The Menarini Group Latest Developments
11.6 Bio-Rad Laboratories Inc.
11.6.1 Bio-Rad Laboratories Inc. Company Information
11.6.2 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Rad Laboratories Inc. Main Business Overview
11.6.5 Bio-Rad Laboratories Inc. Latest Developments
11.7 QIAGEN Inc.
11.7.1 QIAGEN Inc. Company Information
11.7.2 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 QIAGEN Inc. Main Business Overview
11.7.5 QIAGEN Inc. Latest Developments
11.8 Exact Sciences Corporation
11.8.1 Exact Sciences Corporation Company Information
11.8.2 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
11.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Exact Sciences Corporation Main Business Overview
11.8.5 Exact Sciences Corporation Latest Developments
11.9 Bio-Techne Corporation
11.9.1 Bio-Techne Corporation Company Information
11.9.2 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
11.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bio-Techne Corporation Main Business Overview
11.9.5 Bio-Techne Corporation Latest Developments
11.10 ArcherDX Inc.
11.10.1 ArcherDX Inc. Company Information
11.10.2 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 ArcherDX Inc. Main Business Overview
11.10.5 ArcherDX Inc. Latest Developments
11.11 Neogenomics Laboratories Inc.
11.11.1 Neogenomics Laboratories Inc. Company Information
11.11.2 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Neogenomics Laboratories Inc. Main Business Overview
11.11.5 Neogenomics Laboratories Inc. Latest Developments
11.12 Guardant Health Inc.
11.12.1 Guardant Health Inc. Company Information
11.12.2 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Guardant Health Inc. Main Business Overview
11.12.5 Guardant Health Inc. Latest Developments
11.13 Myriad Genetics Inc.
11.13.1 Myriad Genetics Inc. Company Information
11.13.2 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Myriad Genetics Inc. Main Business Overview
11.13.5 Myriad Genetics Inc. Latest Developments
11.14 Foundation Medicine Inc.
11.14.1 Foundation Medicine Inc. Company Information
11.14.2 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
11.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Foundation Medicine Inc. Main Business Overview
11.14.5 Foundation Medicine Inc. Latest Developments
11.15 Amoy Diagnostics Co. Ltd.
11.15.1 Amoy Diagnostics Co. Ltd. Company Information
11.15.2 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
11.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Amoy Diagnostics Co. Ltd. Main Business Overview
11.15.5 Amoy Diagnostics Co. Ltd. Latest Developments
11.16 Biocartis Group NV
11.16.1 Biocartis Group NV Company Information
11.16.2 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Offered
11.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Biocartis Group NV Main Business Overview
11.16.5 Biocartis Group NV Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Liquid Biopsy For Cancer Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Test
Table 4. Major Players of Urine Test
Table 5. Major Players of Saliva Test
Table 6. Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Liquid Biopsy For Cancer Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Liquid Biopsy For Cancer Diagnostics Key Players Head office and Products Offered
Table 15. Liquid Biopsy For Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Liquid Biopsy For Cancer Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Liquid Biopsy For Cancer Diagnostics
Table 40. Key Market Challenges & Risks of Liquid Biopsy For Cancer Diagnostics
Table 41. Key Industry Trends of Liquid Biopsy For Cancer Diagnostics
Table 42. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. F. Hoffman La Roche Ltd. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 47. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 48. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. F. Hoffman La Roche Ltd. Main Business
Table 50. F. Hoffman La Roche Ltd. Latest Developments
Table 51. Thermo Fisher Scientific Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 53. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Thermo Fisher Scientific Inc. Main Business
Table 55. Thermo Fisher Scientific Inc. Latest Developments
Table 56. Agilent Technologies Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 57. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 58. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Agilent Technologies Inc. Main Business
Table 60. Agilent Technologies Inc. Latest Developments
Table 61. Illumina Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 62. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 63. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Illumina Inc. Main Business
Table 65. Illumina Inc. Latest Developments
Table 66. The Menarini Group Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 67. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Offered
Table 68. The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. The Menarini Group Main Business
Table 70. The Menarini Group Latest Developments
Table 71. Bio-Rad Laboratories Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 72. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 73. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Bio-Rad Laboratories Inc. Main Business
Table 75. Bio-Rad Laboratories Inc. Latest Developments
Table 76. QIAGEN Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 77. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 78. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. QIAGEN Inc. Main Business
Table 80. QIAGEN Inc. Latest Developments
Table 81. Exact Sciences Corporation Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 82. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
Table 83. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Exact Sciences Corporation Main Business
Table 85. Exact Sciences Corporation Latest Developments
Table 86. Bio-Techne Corporation Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 87. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
Table 88. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Bio-Techne Corporation Main Business
Table 90. Bio-Techne Corporation Latest Developments
Table 91. ArcherDX Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 92. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 93. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. ArcherDX Inc. Main Business
Table 95. ArcherDX Inc. Latest Developments
Table 96. Neogenomics Laboratories Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 97. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 98. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Neogenomics Laboratories Inc. Main Business
Table 100. Neogenomics Laboratories Inc. Latest Developments
Table 101. Guardant Health Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 102. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 103. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Guardant Health Inc. Main Business
Table 105. Guardant Health Inc. Latest Developments
Table 106. Myriad Genetics Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 107. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 108. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Myriad Genetics Inc. Main Business
Table 110. Myriad Genetics Inc. Latest Developments
Table 111. Foundation Medicine Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 112. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 113. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Foundation Medicine Inc. Main Business
Table 115. Foundation Medicine Inc. Latest Developments
Table 116. Amoy Diagnostics Co. Ltd. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 117. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 118. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Amoy Diagnostics Co. Ltd. Main Business
Table 120. Amoy Diagnostics Co. Ltd. Latest Developments
Table 121. Biocartis Group NV Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 122. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Offered
Table 123. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Biocartis Group NV Main Business
Table 125. Biocartis Group NV Latest Developments
Table 1. Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Liquid Biopsy For Cancer Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Test
Table 4. Major Players of Urine Test
Table 5. Major Players of Saliva Test
Table 6. Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Liquid Biopsy For Cancer Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Liquid Biopsy For Cancer Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Liquid Biopsy For Cancer Diagnostics Key Players Head office and Products Offered
Table 15. Liquid Biopsy For Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Liquid Biopsy For Cancer Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Liquid Biopsy For Cancer Diagnostics
Table 40. Key Market Challenges & Risks of Liquid Biopsy For Cancer Diagnostics
Table 41. Key Industry Trends of Liquid Biopsy For Cancer Diagnostics
Table 42. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. F. Hoffman La Roche Ltd. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 47. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 48. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. F. Hoffman La Roche Ltd. Main Business
Table 50. F. Hoffman La Roche Ltd. Latest Developments
Table 51. Thermo Fisher Scientific Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 53. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Thermo Fisher Scientific Inc. Main Business
Table 55. Thermo Fisher Scientific Inc. Latest Developments
Table 56. Agilent Technologies Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 57. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 58. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Agilent Technologies Inc. Main Business
Table 60. Agilent Technologies Inc. Latest Developments
Table 61. Illumina Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 62. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 63. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Illumina Inc. Main Business
Table 65. Illumina Inc. Latest Developments
Table 66. The Menarini Group Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 67. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Offered
Table 68. The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. The Menarini Group Main Business
Table 70. The Menarini Group Latest Developments
Table 71. Bio-Rad Laboratories Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 72. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 73. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Bio-Rad Laboratories Inc. Main Business
Table 75. Bio-Rad Laboratories Inc. Latest Developments
Table 76. QIAGEN Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 77. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 78. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. QIAGEN Inc. Main Business
Table 80. QIAGEN Inc. Latest Developments
Table 81. Exact Sciences Corporation Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 82. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
Table 83. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Exact Sciences Corporation Main Business
Table 85. Exact Sciences Corporation Latest Developments
Table 86. Bio-Techne Corporation Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 87. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Offered
Table 88. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Bio-Techne Corporation Main Business
Table 90. Bio-Techne Corporation Latest Developments
Table 91. ArcherDX Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 92. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 93. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. ArcherDX Inc. Main Business
Table 95. ArcherDX Inc. Latest Developments
Table 96. Neogenomics Laboratories Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 97. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 98. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Neogenomics Laboratories Inc. Main Business
Table 100. Neogenomics Laboratories Inc. Latest Developments
Table 101. Guardant Health Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 102. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 103. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Guardant Health Inc. Main Business
Table 105. Guardant Health Inc. Latest Developments
Table 106. Myriad Genetics Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 107. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 108. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Myriad Genetics Inc. Main Business
Table 110. Myriad Genetics Inc. Latest Developments
Table 111. Foundation Medicine Inc. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 112. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 113. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Foundation Medicine Inc. Main Business
Table 115. Foundation Medicine Inc. Latest Developments
Table 116. Amoy Diagnostics Co. Ltd. Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 117. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Offered
Table 118. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Amoy Diagnostics Co. Ltd. Main Business
Table 120. Amoy Diagnostics Co. Ltd. Latest Developments
Table 121. Biocartis Group NV Details, Company Type, Liquid Biopsy For Cancer Diagnostics Area Served and Its Competitors
Table 122. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Offered
Table 123. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Biocartis Group NV Main Business
Table 125. Biocartis Group NV Latest Developments
LIST OF FIGURES
Figure 1. Liquid Biopsy For Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Liquid Biopsy For Cancer Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type in 2025
Figure 10. Liquid Biopsy For Cancer Diagnostics in Hospital
Figure 11. Global Liquid Biopsy For Cancer Diagnostics Market: Hospital (2021-2026) & ($ millions)
Figure 12. Liquid Biopsy For Cancer Diagnostics in Diagnostic Center
Figure 13. Global Liquid Biopsy For Cancer Diagnostics Market: Diagnostic Center (2021-2026) & ($ millions)
Figure 14. Liquid Biopsy For Cancer Diagnostics in Others
Figure 15. Global Liquid Biopsy For Cancer Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 16. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application in 2025
Figure 17. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Player in 2025
Figure 18. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. APAC Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Europe Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Americas Liquid Biopsy For Cancer Diagnostics Value Market Share by Country in 2025
Figure 24. United States Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region in 2025
Figure 29. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 31. China Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Country in 2025
Figure 38. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. APAC Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. Europe Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. United States Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Canada Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. China Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Japan Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. Korea Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. India Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Australia Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. Germany Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. France Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. UK Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Italy Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. Russia Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Israel Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 1. Liquid Biopsy For Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liquid Biopsy For Cancer Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Liquid Biopsy For Cancer Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Liquid Biopsy For Cancer Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type in 2025
Figure 10. Liquid Biopsy For Cancer Diagnostics in Hospital
Figure 11. Global Liquid Biopsy For Cancer Diagnostics Market: Hospital (2021-2026) & ($ millions)
Figure 12. Liquid Biopsy For Cancer Diagnostics in Diagnostic Center
Figure 13. Global Liquid Biopsy For Cancer Diagnostics Market: Diagnostic Center (2021-2026) & ($ millions)
Figure 14. Liquid Biopsy For Cancer Diagnostics in Others
Figure 15. Global Liquid Biopsy For Cancer Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 16. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application in 2025
Figure 17. Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Player in 2025
Figure 18. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 20. APAC Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 21. Europe Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Americas Liquid Biopsy For Cancer Diagnostics Value Market Share by Country in 2025
Figure 24. United States Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region in 2025
Figure 29. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 31. China Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Country in 2025
Figure 38. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Liquid Biopsy For Cancer Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 54. APAC Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 55. Europe Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. United States Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Canada Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. China Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Japan Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. Korea Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. India Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Australia Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. Germany Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. France Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. UK Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Italy Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. Russia Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Israel Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Liquid Biopsy For Cancer Diagnostics Market Size 2027-2032 ($ millions)
